Sub-Groups

• Breast Medicine Service (3320)
• Clinical Genetics Service (869)
• Early Drug Development Service (365)
• Exercise Oncology Service (157)
• Gastrointestinal Oncology Service (3233)
• Genitourinary Oncology Service (4340)
• Gynecologic Medicine Service (1431)
• Head and Neck Service (584)
• Melanoma and Immunotherapeutics Service (1501)
• Sarcoma Service (573)
• Thoracic Oncology (2155)

Types of Work

["2020"]

[[["Journal Articles",8716],["Meeting Abstracts",6699],["Book Sections",365],["Reviews",112],["Conference Papers",90],["Editorials",78],["Guidelines",38],["Books Whole",27],["Correspondences",26],["Research Letters",14],["Miscellaneous",12]]]

[16177]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• major clinical study
• male
• middle aged
• priority journal

Recent Works

1. Selpercatinib (LOXO-292) in patients with RET-fusion+ non small-cell lung cancer (NSCLC)

   Meeting Abstract

   Goto, K.; Oxnard, G.; Tan, Dswsw; Loong, H. H. F.; Bauer, T. T.; Gainor, J.; McCoach, C.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
   Pneumologie (2021)

   Fulltext@MSK | Save
2. Registrational phase 2 trial of sotorasib in KRAS p. G12C mutant NSCLC: First disclosure of the CodeBreaK 100 primary analysis

   Meeting Abstract

   Schuler, M.; Li, B. T.; Skoulidis, F.; Falchook, G.; Sacher, A.; Velcheti, V.; Dy, G. K.; Price, T.; Borghaei, H.; Kato, T.; more...
   Pneumologie (2021)

   Fulltext@MSK | Save
3. Neoadjuvantes osimertinib mit/ohne chemotherapie vs.chemotherapie bei EGFRmutiertem resektablem NSCLC: NeoADAURA

   Meeting Abstract

   Griesinger, F.; Tsuboi, M.; Weder, W.; Escriu, C.; Blakely, C.; He, J.; Dacic, S.; Yatabe, Y.; Zeng, L.; Walding, A.; more...
   Pneumologie (2021)

   Fulltext@MSK | Save